Advanced Malignant Neoplasm Clinical Trials

45 clinical trials for Advanced Malignant Neoplasm across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) — RECRUITING · PHASE1
• A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies — RECRUITING · PHASE1
• A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors — RECRUITING · PHASE1
• Combination Chemotherapy and Bevacizumab With the NovoTTF-100L(P) System in Treating Participants With Advanced, Recurrent, or Refractory Hepatic Metastatic Cancer — TERMINATED · PHASE1
• RCT of QPS vs General Information Sheet — ACTIVE_NOT_RECRUITING · NA
• Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor — ACTIVE_NOT_RECRUITING · PHASE1
• Talazoparib in Treating Patients With Recurrent, Refractory, Advanced, or Metastatic Cancers and Alterations in the BRCA Genes — ACTIVE_NOT_RECRUITING · PHASE2
• Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease — TERMINATED · PHASE1
• First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia — ACTIVE_NOT_RECRUITING · PHASE1
• A Phase 1 Clinical Trial of AUR106 in Patients With Relapsed Advanced Malignancies — TERMINATED · PHASE1
• A Study of Cancer Related Fatigue in Patients With Metastatic Cancer Receiving Anti-PD1 Immunotherapy — ACTIVE_NOT_RECRUITING · PHASE3
• Financial Distress in Advanced Cancer Patients — ACTIVE_NOT_RECRUITING
• Preference of Room Setting and Waiting Time in Patients With Advanced, Locally Advanced, or Metastatic Cancer and Their Caregivers Who Are Seen in the Outpatient Supportive/Palliative Care Center — ACTIVE_NOT_RECRUITING · NA
• Physical Activity and Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Advanced Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Haloperidol With or Without Chlorpromazine in Treating Delirium in Patients With Advanced, Metastatic, or Recurrent Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Cordotomy in Reducing Pain in Patients With Advanced Cancer — ACTIVE_NOT_RECRUITING · NA
• Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study — COMPLETED
• Vandetanib and Everolimus in Treating Patients With Advanced or Metastatic Cancer — COMPLETED · PHASE1
• A Clinical Study of TQB3912 Tablets in Patients With Advanced Malignant Tumor — COMPLETED · PHASE1
• Expanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid Tumors — OTHER
• A Clinical Trial of TQB3006 Tablets in Patients With Advanced Malignant Cancer — COMPLETED · PHASE1
• Fat Emulsion in Preventing Hypersensitivity Reactions in Patients With Cancer Receiving Carboplatin or Oxaliplatin — COMPLETED · NA
• Videos and Questionnaires in Assessing Patient Perception of Physician's Compassion, Communication Skills, and Professionalism During Clinic Visits — COMPLETED · NA
• TQB2928 Injection Combined With Penpulimab in Treatment of Advanced Malignant Tumors. — TERMINATED · PHASE1
• A Study to Evaluate the Efficacy and Safety of QLF31907 Combination Therapy in Patients With Advanced Malignant Tumors — NOT_YET_RECRUITING · PHASE1
• Pre-Test Genetic Education and Remote Genetic Counseling in Communicating Tumor Profiling Results to Patients With Advanced Cancer — COMPLETED · NA
• A Clinical Trial of TQB3015 Tablets in Patients With Advanced Malignant Cancer — WITHDRAWN · PHASE1
• A Study to Evaluate Drug-Drug Interaction of TQB3909 Tablets — OTHER · PHASE1
• Clinical Application of Lutetium [177Lu]-Catalase in Tumor Radionuclide Therapy — OTHER · PHASE1
• Clinical Trial Evaluating the Safety of the TQB2103 for Injection — OTHER · PHASE1
• Muscadine Grape Skin Extract in Treating Patients With Malignancy That Is Metastatic or Cannot Be Removed by Surgery — COMPLETED · PHASE1
• A Clinical Study of 6MW3211 Injection in the Treatment of Advanced Malignant Neoplasm — OTHER · PHASE1
• Caregiver Burden, Quality of Life, and Symptom Distress at Different Palliative Cancer Care Settings — COMPLETED
• Brigatinib in Treating Patients With ALK and ROS1 Gene Alterations and Locally Advanced or Metastatic Solid Cancers — WITHDRAWN · PHASE2
• Enhancing Connections Program in Improving Family Adjustment in Patients With Incurable Cancer — TERMINATED · NA
• First-in-Human Study of KO-947 in Non-Hematological Malignancies — TERMINATED · PHASE1
• Ethyl Icosapentate and Physical Activity in Treating Fatigue in Patients With Advanced Cancer — TERMINATED · PHASE2
• Everolimus and Anakinra or Denosumab in Treating Participants With Relapsed or Refractory Advanced Cancers — COMPLETED · PHASE1
• Vemurafenib With Sorafenib Tosylate or Crizotinib in Treating Patients With Advanced Malignancies With BRAF Mutations — COMPLETED · PHASE1
• Rectal Administration of Opioids Using the Macy Catheter in Reducing Pain in Patients With Advanced Cancer — WITHDRAWN · NA
• Spironolactone in Preventing Rash in Patients With Advanced Cancer Receiving Panitumumab and Cetuximab — COMPLETED · PHASE2
• Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations — COMPLETED · PHASE1
• Enhancing Connections Program in Improving Communication Between Patients With Incurable Cancer and Their Children — COMPLETED · NA
• Tipifarnib and Sorafenib Tosylate in Treating Patients With Biopsiable Advanced Cancer — COMPLETED · PHASE1
• The Real Clinical Background of Advanced Colorectal Cancer Treatment Situation Survey — OTHER

Refine this search